ALESSANDRA FUSCO; SARA COLARUSSO; MARCO PISCOPO; MARIA ROSARIA IMPROTA; MARCO CORIGLIANO. Short-term Cardio-Vascular Risk Score Changes in Type 2 Diabetic Patients on Empaglifozin: A Real-Life Clinical Experience. Heart Research, [S. l.], v. 4, n. 3, p. 46–56, 2017. DOI: 10.17140/HROJ-4-141. Disponível em: https://openventio.us/index.php/HROJ/article/view/816. Acesso em: 14 nov. 2026.